Clinical trial
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients…
NCT00062062 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00062062 |
|---|---|
| Title | Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer |
| Official title | Parallel Phase II Trials of ZD1839 (Iressa) Alone or Weekly Carboplatin and Paclitaxel Followed by ZD1839 (Iressa) (Oncologists Must Choose) for Metastatic Non-Small Cell Lung Cancer in Patients > or = 65 Years of Age |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, gefitinib, paclitaxel |
| Enrollment | 65 |
| Start date | Oct 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Nov 1, 2010 |
| First posted | Jun 6, 2003 |
| Last update posted | Dec 14, 2016 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: